NewGenIvf Group Ltd

Prior to the Business Combination, on April 29, 2021, A SPAC I Acquisition Corp. ( ASCA ), was incorporated as a British Virgin Islands business company, specifically a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more target businesses. The Business Combination On February 15, 2023, ASCA entered into the Merger Agreement (as amended on June 12, 2023 and December 6, 2023, the Merger Agreement, and the transactions contemplated thereunder, the Business Combination ) with A SPAC I Mini Acquisition Corp., Merger Sub, NewGenIvf Limited, a Cayman Islands exempted company ( Legacy NewGenIvf ) and certain shareholders of Legacy NewGenIvf. Pursuant to the Merger Agreement, the Business Combination was effected in two steps: (i) ASCA was reincorporated to the British Virgin Islands by merging with and into A SPAC I Mini Acquisition Corp. (such transaction, the Reincorporation Merger ); and (ii) Merger Sub merged with and into Legacy NewGenIvf, resulting in Legacy NewGenIvf being a wholly-owned subsidiary of the Company (such second step in isolation, the Acquisition Merger ). The surviving entity of the Business Combination, together with its subsidiaries is referred to in this prospectus as NewGenIvf, the Company, we, our, or us, unless the context otherwise requires.